Carmen Scheibenbogen

15.1k total citations · 2 hit papers
244 papers, 9.8k citations indexed

About

Carmen Scheibenbogen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Carmen Scheibenbogen has authored 244 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Immunology, 67 papers in Oncology and 60 papers in Molecular Biology. Recurrent topics in Carmen Scheibenbogen's work include Immunotherapy and Immune Responses (82 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (58 papers) and T-cell and B-cell Immunology (49 papers). Carmen Scheibenbogen is often cited by papers focused on Immunotherapy and Immune Responses (82 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (58 papers) and T-cell and B-cell Immunology (49 papers). Carmen Scheibenbogen collaborates with scholars based in Germany, United States and United Kingdom. Carmen Scheibenbogen's co-authors include Ulrich Keilholz, Anne Letsch, Eckhard Thiel, Alexander Schmittel, Sandra Bauer, Reinhard Andreesen, Dirk Nagorsen, Klaus Wirth, Hans‐Dieter Volk and Anne Marie Asemissen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Carmen Scheibenbogen

239 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity

2022 169 citations Claudia Kedor, Helma Freitag et al. Nature Communications profile →
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)

2022 168 citations Helma Freitag, Gordon Rudolf et al. Journal of Translational Medicine profile →

Peers

Countries citing papers authored by Carmen Scheibenbogen

Since Specialization

Citations

This map shows the geographic impact of Carmen Scheibenbogen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Scheibenbogen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Scheibenbogen more than expected).

Fields of papers citing papers by Carmen Scheibenbogen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Scheibenbogen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Scheibenbogen. The network helps show where Carmen Scheibenbogen may publish in the future.

Co-authorship network of co-authors of Carmen Scheibenbogen

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Scheibenbogen. A scholar is included among the top collaborators of Carmen Scheibenbogen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Scheibenbogen. Carmen Scheibenbogen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional olfactory impairment and fatigue in post-COVID-19 syndrome including ME/CFS – a longitudinal prospective observational study 2025 ·Brain Behavior & Immunity - Health ·Lil Meyer‐Arndt, (unknown), (unknown), (unknown), (unknown), (unknown), Claudia Kedor, Kirsten Wittke, Helma Freitag, Frank Konietschke, Heidi Olze, Friedemann Paul, Carmen Scheibenbogen, Judith Bellmann–Strobl, Ulrike Förster‐Ruhrmann	0
2	The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction 2024 ·European Heart Journal ·Carsten Skurk, Zehra Karadeniz, (unknown), Henrike Maatz, Erika Lindberg, Tobias Haase, (unknown), N Kraenkel, Matthias Taupitz, Ulrich Kintscher, Jens Kurreck, Wolfgang Poller, Carmen Scheibenbogen, Ulf Landmesser, (unknown)	0
3	Graded exercise therapy should not be recommended for patients with post-exertional malaise 2024 ·Nature Reviews Cardiology ·(unknown), Merel E. Hellemons, (unknown), Kathryn Hoffmann, Joanne VanDerNagel, Todd E. Davenport, Eva Untersmayr, Carmen Scheibenbogen, David Putrino	6
4	Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome 2024 ·Infection ·(unknown), Diana Dudziak, Carmen Scheibenbogen, Martina Seifert, Franziska Sotzny, Carsten Finke, Uta Behrends, Konrad Aden, (unknown), Dirk Brockmann, (unknown), Wilhelm Bloch, (unknown), Anuradha Ramoji, Jürgen Popp, Philipp A. Reuken, Martin A. Walter, Andreas Stallmach, Christian Puta	10
5	A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms 2024 ·ERJ Open Research ·Fridolin Steinbeis, Claudia Kedor, (unknown), Charlotte Thibeault, Mirja Mittermaier, Philipp Knape, Katharina Ahrens, Gabriele Rotter, Bettina Temmesfeld‐Wollbrück, Leif Erik Sander, Florian Kurth, Martin Witzenrath, Carmen Scheibenbogen, Thomas Zöller	1
6	Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated Evidence 2024 ·Journal of Cachexia Sarcopenia and Muscle ·Carmen Scheibenbogen, Klaus Wirth	9
7	Structural brain changes in patients with post-COVID fatigue: a prospective observational study 2023 ·EClinicalMedicine ·J. Heine, (unknown), Tim J. Hartung, (unknown), Claudia Chien, (unknown), Rebekka Rust, Christian Hohenfeld, (unknown), Ana S.H. Costa, Carmen Scheibenbogen, Judith Bellmann–Strobl, Friedemann Paul, Christiana Franke, Kathrin Reetz, Carsten Finke	60
8	Clinical and immunological characterisation of patients with common variable immunodeficiency related immune thrombocytopenia 2023 ·Clinical and Experimental Medicine ·(unknown), Oliver Meyer, Carmen Scheibenbogen, Leif G. Hanitsch, Anna Stittrich, Uwe Kölsch, Kirsten Wittke	3
9	Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort 2023 ·EClinicalMedicine ·(unknown), Lil Meyer‐Arndt, (unknown), Claudia Kedor, Helma Freitag, (unknown), (unknown), Rebekka Rust, Kirsten Wittke, Nadja Siebert, Janina Behrens, Andreas Thiel, Frank Konietschke, Friedemann Paul, Carmen Scheibenbogen, Judith Bellmann–Strobl	52
10	Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS 2023 ·Journal of Clinical Medicine ·(unknown), Claudia Kedor, Frank Buttgereit, Harald Heidecke, (unknown), Carmen Scheibenbogen	3
11	Salivary Diagnostic for Monitoring Strenuous Exercise—A Pilot Study in a Cohort of Male Ultramarathon Runners 2022 ·International Journal of Environmental Research and Public Health ·(unknown), Cordula Leonie Merle, (unknown), (unknown), (unknown), Bernd Wolfarth, Tanja Kottmann, Carmen Scheibenbogen, (unknown), Sven Diederich, (unknown), Ulrich Sack, Gerhard Schmalz, Dirk Ziebolz, (unknown)	5
12	A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity breakdown → 2022 ·Nature Communications ·Claudia Kedor, Helma Freitag, Lil Meyer‐Arndt, Kirsten Wittke, Leif G. Hanitsch, Thomas Zöller, Fridolin Steinbeis, (unknown), Gordon Rudolf, Bettina Heidecker, Thomas Bobbert, Joachim Spranger, Hans‐Dieter Volk, Carsten Skurk, Frank Konietschke, Friedemann Paul, Uta Behrends, Judith Bellmann–Strobl, Carmen Scheibenbogen	169
13	Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2022 ·Journal of Translational Medicine ·(unknown), Carmen Scheibenbogen, Peter Linz, Christian Stehning, Klaus Wirth, Titus Küehne, Marcus Kelm	14
14	Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study 2021 ·Journal of Clinical Medicine ·Carmen Scheibenbogen, Franziska Sotzny, Jelka Hartwig, Sandra Bauer, Helma Freitag, Kirsten Wittke, Wolfram Doehner, Nadja Scherbakov, Madlen Loebel, Patricia Grabowski	7
15	Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2020 ·ImmunoHorizons ·(unknown), Thomas Harrer, Carmen Scheibenbogen, Stephanie Lamer, Andreas Schlösser, Robert K. Naviaux, Bhupesh K. Prusty	45
16	Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology 2020 ·Journal of Clinical Medicine ·Fernando Estévez‐López, Kathleen Mudie, Xia Wang, Inger Johanne Bakken, (unknown), Jesús Castro‐Marrero, Luís Nacul, José Alegre, Paweł Zalewski, Joanna Słomko, Elin Bolle Strand, Derek Pheby, Evelina Shikova, Lorenzo Lorusso, Enrica Capelli, Slobodan Sekulić, Carmen Scheibenbogen, Nuno Sepúlveda, Modra Murovska, Eliana Lacerda	50
17	Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review 2018 ·BMJ Open ·Fernando Estévez‐López, Jesús Castro‐Marrero, Xia Wang, Inger Johanne Bakken, (unknown), Luís Nacul, Nuno Sepúlveda, Elin Bolle Strand, Derek Pheby, José Alegre, Carmen Scheibenbogen, Evelina Shikova, Lorenzo Lorusso, Enrica Capelli, Slobodan Sekulić, Eliana Lacerda, Modra Murovska	21
18	Abstract 11247: The Long Noncoding MALAT1 - MascRNA System is a Novel Regulator of Cardiac Innate Immunity 2014 ·Circulation ·Wolfgang Poller, Martina Gast, Blanche Schroen, Antje Voigt, Jan Haas, Anna Papageorgiou, Uwe Kuehl, Dirk Laßner, Xiaomin Wang, Madlen Loebel, Sabrina Wilk, Nadine Althof, T. J. Peters, Kannanganattu V. Prasanth, Hugo A. Katus, Benjamin Meder, Shinichi Nakagawa, Carmen Scheibenbogen, Stéphane Heymans	1
19	Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy 2002 ·Journal of Immunotherapy ·Ulrich Keilholz, Jeffrey S. Weber, James H. Finke, Dmitry I. Gabrilovich, W. Martin Kast, Mary L. Disis, John M. Kirkwood, Carmen Scheibenbogen, Jeff Schlom, Vernon C. Maino, H. Kim Lyerly, Peter P. Lee, Walter J. Storkus, (unknown), Alexandra S. Worobec, Michael B. Atkins	235
20	Regulation of Neopterin Secretion during Human Monocyte to Macrophage Differentiation in Vitro 1990 ·Pteridines ·Reinhard Andreesen, Carmen Scheibenbogen, Marina Kreutz, Stefan W. Krause, Annegret Rehm	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact